Original Contribution |
From Cardiologie Cellulaire et Moléculaire (E.D.S., V.V., P.M., E.M., J.H., R.V.-C.), U-446 INSERM, Faculté de Pharmacie, Université Paris-Sud, Châtenay-Malabry, France; Unité de Bioénergétique (X.B., B.S.), Centre de Recherches du Service de Santé des Armées, La Tronche, France; and Departments of Pharmacology and Pathological Anatomy (A.M., A.K.), Medical Faculty, Tartu University, Tartu, Estonia.
Correspondence to Renée Ventura-Clapier, Cardiologie Cellulaire et Moléculaire, U-446 INSERM, Université Paris-Sud, Faculté de Pharmacie, 92296 Châtenay-Malabry, France. E-mail renee.ventura{at}cep.u-psud.fr
| Abstract |
|---|
|
|
|---|
-myosin heavy-chain expression decreased, whereas
calcium sensitivity of tension development remained unaltered.
Myofibrillar CK efficacy was unchanged. Calcium uptake capacities of SR
were estimated from the surface of caffeine-induced tension transient
(SCa) after loading with different substrates. In CHF,
SCa decreased by 23%, and phosphocreatine was 2 times less
efficient in enhancing calcium uptake. Oxidative capacities of the
failing myocardium measured as oxygen consumption per gram
of fiber dry weight decreased by 28%. Moreover, the control of
respiration by creatine, ADP, and AMP was severely impaired. Our
observations provide evidence that alterations in CK compartmentation
may contribute to alterations of energy fluxes and calcium homeostasis
in CHF.
Key Words: mitochondrial respiration myofibril compartmentation sarcoplasmic reticulum skinned fiber
| Introduction |
|---|
|
|
|---|
CK is an important enzyme involved in energy maintenance and energy transfer in muscle and brain cells. It catalyzes the reversible transfer of a phosphate moiety between ATP and creatine. Four different isoforms of CK are expressed in a tissue-specific and developmentally regulated manner. A major part of muscle CK exists as dimers composed of 2 subunits, M and B, giving 3 isoenzymes, MM, BB, and MB. In addition, there is a fourth isoenzyme in the mitochondria (sarcomeric mitochondrial CK [mi-CK]), which differs biochemically and immunochemically from the cytosolic forms and can form both octameric and dimeric structures.8 In muscle cells, reactions involved in ATP generation and utilization are not governed by stochastic events, but rather occur within structural and functional entities and are spatially and temporarily coordinated. CK isoenzymes are not evenly distributed in the cardiac cell, but the CK system constitutes an example of a compartmentalized metabolic pathway. MM-CK has been found in myofibrils and described as a structural protein of the M band participating in the connections between myosin filaments inside muscle fibers.9 This bound MM-CK is functionally coupled to the myosin ATPase and can provide enough energy to sustain maximal force and normal kinetics of contraction (for review, see Reference 1010 and references therein). Similarly, MM-CK is strongly bound to sarcoplasmic reticulum (SR) membranes, in which it is functionally coupled to the Ca2+-ATPase, and ensures efficient energy provision of the SR by the local regeneration of ATP.11 12 13 14 mi-CK is found on the outer surface of the inner mitochondrial membrane, in the vicinity of the ATP-ADP carrier, so that ATP generated by oxidative phosphorylation, after transport through the inner mitochondrial membrane, is transphosphorylated to PCr (for review, see References 15 and 1615 16 and references therein). The sites of energy production and energy utilization are integrated through near-equilibrium reactions of CK in the cytosol, promoting sequential equilibration that results in almost instantaneous transfer of phosphoryl groups and metabolic signal.8 16 It is conceivable that altered compartmentation of the CK isoenzymes in congestive heart failure (CHF) may impair the functioning of intracellular compartments, thus compromising integration between energy production and utilization.
The goal of this study was to investigate the role of bound CK isoforms on the intrinsic functional properties of the 3 main intracellular cardiac compartments involved in excitation-contraction coupling (myofibrils and SR) and energy production (mitochondria) and their alterations in heart failure. Using an animal model of prolonged chronic heart failure induced by aortic banding, we examined (1) whether the function of these cellular compartments is altered in heart failure, (2) whether alterations in localized CK isoforms may alter the regulation and function of these subcellular compartments, and (3) how these alterations may contribute to the pathophysiology of heart failure.
| Materials and Methods |
|---|
|
|
|---|
After induction of anesthesia with intraperitoneal injection of pentobarbital (60 mg/kg), aortic stenosis was created in weaned male rats (60 to 70 g) by placing a stainless steel hemoclip of 0.6-mm ID on the ascending aorta via a thoracic incision (CHF group).17 Age-matched controls underwent the same procedure without placement of the clip (sham group). All rats were fed a normal chow diet and water ad libitum with a 12-hour/12-hour photoperiod. This investigation was carried out in accordance with the Helsinki Recommendations for Humane Treatment of Animals during Experimentation.
Seven months after surgery, mortality was
70% in the CHF group, and
13 CHF rats and 15 sham rats were studied. Animals were
anesthetized with an intraperitoneal
injection of urethane (0.2 g/100 g). Right and left ventricles were
isolated and weighed. Parts of the left ventricles were rapidly frozen
in liquid nitrogen for biochemical and morphological determinations,
and other parts were immediately used for respiration or mechanical
experiments. Additionally, lungs, kidneys, and liver were blotted and
weighed. Left tibia length was measured.
To confirm the existence of heart failure, the mechanical function was assessed in Langendorff-perfused hearts of the sham and CHF groups (n=4). Hearts were retrogradely perfused with Krebs Henseleit solution containing 10 mmol/L glucose as substrate and 1.75 mmol/L CaCl2. The flow per gram wet weight (ww) was kept constant in both series (8 mL/min per gram ww). Hearts were stimulated at 240 bpm. A balloon, inserted in the left ventricle, was progressively inflated to reach the plateau of the pressure/volume relationship (the volume required was 240 µL in CHF and 260 µL in sham). LV developed pressure (LVDP) and LV end diastolic pressure (LVEDP) were analyzed online. The "arterial" PO2 (PaO2) just above the aorta and "venous" PO2 (PvO2) in the pulmonary artery were measured online through 2 flow cells, Clark electrodes, and an oxymeter (Stratkhelvin Institute). The oxygen consumption (PaO2PvO2) was expressed in µmol O2/min per gram ww (QO2).
Morphological and Biochemical Studies
Collagen was quantified using a histological
method. Cryosections of left ventricle were exposed to hematoxylin and
then to acid fuchsin according to the van Gieson method. Three or four
areas of each transverse section representative of the
left ventricle were magnified, and video images of the section were
digitized (Visiolab 200 image-processing system, Biocom).
Frozen tissue samples were weighed; homogenized in ice-cold buffer (50 mg/mL) containing (in mmol/L) HEPES 5 (pH 8.7), EGTA 1, DTT 1, and MgCl2 5, and 0.1% Triton X-100; and incubated for 60 minutes at 0°C to ensure complete enzyme extraction. The total activities of adenylate kinase (AK), CK, pyruvate kinase (PK), phosphoglycerate kinase (PGK), and lactate dehydrogenase (LDH) were assayed (30°C, pH 7.5) using coupled enzyme systems as previously described.18 19
CK isoenzymes were separated using agarose (1%) gel electrophoresis performed at 200 V for 90 minutes; individual isoenzymes were resolved by incubating the gels with a coupled enzyme system.19 Internal standards of commercial MM-CK were run in parallel with tissue samples to ensure linearity in isoenzyme quantification. To avoid saturation of the various CK isoform signals, 3 dilutions were run for each sample. Isoenzyme bands were visualized by the fluorescence of NADPH. The LDH isoenzyme profile was determined using agarose gel electrophoresis (Sigma LDH reagent kit) at 200 V for 90 minutes. Gels were quantified using an image-analysis system (Bio-Rad). Activity of CK and LDH isoenzymes was quantified by multiplying each percentage by total activity, as determined spectrophotometrically. Determination of citrate synthase activity was performed according to Srere.20 Protein concentration was determined with the Lowry method, using BSA as a standard.
Native myosin was extracted from frozen tissues according to d'Albis et al.21 Myosin isoforms were separated by PAGE. Gel-running buffer consisted of 20 mmol/L sodium pyrophosphate (pH 8.5), 10% glycerol, 0.01% 2-mercaptoethanol, and 2 mmol/L MgCl2. Cylindrical (6x0.5-cm) gels contained 4% polyacrylamide (3.88% acrylamide and 0.12% N,N'-methylene-bis-acrylamide). Between 1 and 5 µg of myosin was loaded on each gel. Electrophoresis was carried out at a constant voltage of 90 V, for 22 hours, between 2°C and 4°C.22
Western Blot Analysis
Protein extracts (1 and 4 µg) from sham and CHF hearts and
from 1 control and 1 mi-CK knockout mouse23 heart were
separated on 12% SDS-polyacrylamide gels and subsequently
transferred to Hybond nitrocellulose membranes (Amersham). Mouse mi-CK
antibody (a kind gift of Drs Z. Khuchua and W. Qin, Washington
University, St Louis, Mo) was produced in rabbit anti-mouse whole
recombinant sarcomeric mi-CK. The membranes were incubated with
the mi-CK antibody for 2 hours. After washing, the membranes were
incubated with horseradish peroxidase anti-rabbit IgG secondary
antibody for 90 minutes and revealed with enhanced chemiluminescent
substrate (ECL+ kit, Amersham). Light emission was
detected by autoradiography and quantified using an
image-analysis system (Bio-Rad). Only 1 band of the appropriate
size (43 kDa) was obtained, and no signal was obtained with the cardiac
extract from the mi-CK knockout mouse, which demonstrates the high
specificity of the antibody.
Functional Properties of Mitochondria and Bound CK and AK
Respiratory parameters of the total mitochondrial
population were studied in situ in saponin-skinned fibers, as
previously described.24 Briefly, thin fiber bundles (100
to 250 µm in diameter) were excised from the endocardial wall of
the left ventricle and incubated for 30 minutes at 4°C in solution S
(see below) containing 50 µg/mL saponin to
permeabilize the sarcolemma. Respiratory rates were
determined using a Clark electrode (Strathkelvin Instruments) in an
oxygraphic cell containing 3 mL of solution R (see below) at 22°C
with continuous stirring. The solubility of oxygen was
230 nmol of
O2/mL in buffer after standard calibration in
water. After measurements, the fiber bundles were carefully removed and
dried. Respiration rates were expressed as µmol
O2/min per gram dry weight. Solutions S and R
contained (in mmol/L) EGTAcalcium-EGTA buffer 10 (free
Ca2+ concentration, 100 nmol/L),
MgCl2 1, taurine 20, DTT 0.5, imidazole 20, and
ionic strength 160 (potassium methanesulphonate).24 25 In
addition, solution S (pH 7.1) contained 5 mmol/L MgATP and 15
mmol/L PCr, and solution R (pH 7.1) contained (in mmol/L)
glutamate 5, malate 2, and phosphate 3, and 2 mg/mL fatty acidfree
BSA. Functional activity of mi-CK in skinned fibers was assessed by the
determination of ADP kinetic parameters in the presence
(20 mmol/L) or absence of creatine. The ADP-stimulated respiration
(VADP) above basal oxygen consumption
(V0) was plotted as a function of [ADP].
The apparent Michaelis-Menten constants
(Kms) for ADP and
VADP were calculated using a nonlinear
fitting of the Michaelis-Menten equation. Maximal respiration rate
(Vmax) was
(VADP+V0).
Acceptor control ratio was calculated as
Vmax/V0. The
functional activity of AK was evaluated by the percentage increase in
the respiration rate after addition of 2 mmol/L AMP in the
presence of 0.2 mmol/L ATP (VAMP%).
One to three determinations were made for each animal.
Mechanical Experiments
Muscle fiber bundles were dissected from papillary muscles of
the left ventricle in a zero-Ca2+ Krebs solution
(pH 7.4) and incubated for 1 hour in a relaxing solution (pCa 9; see
solutions below) containing 1% Triton X-100 to solubilize the
membranes. Bundles were mounted between a vibrator and a force
transducer (model AE 801, SensoNor Microelectroniks) as previously
described.18 Sarcomere length was measured by laser
diffraction and adjusted to 2.1 to 2.2 µm. Muscles were immersed
in 2.5-mL chambers continuously stirred at high speed (22°C).
Solutions were prepared according to Fabiato26 as
previously described27 and contained (in mmol/L) EGTA
10, imidazole 30 (pH 7.1), Na+ 30.6,
Mg2+ 3.16, and DTT 0.3, with acetate as anion.
Ionic strength was adjusted to 160 mmol/L with potassium acetate.
pCa was 9 in relaxing and rigor solutions and 4.5 in activating
solution. Relaxing and activating solutions also contained 3.16
mmol/L MgATP and 12 mmol/L PCr. Rigor solutions were obtained by
mixing 2 solutions of pMgATP 2.5 and 6 (without 12 mmol/L PCr) or
pMgATP 4 and 6 (with PCr). pCa (or pMgATP)/tension relationships
were determined under isometric conditions by stepwise changes in
calcium or MgATP concentrations until maximal tension was reached. Data
were fitted using a nonlinear fit of the Hill equation, as follows:
T=Ln/(K+Ln),
where L is the ligand concentration (ATP or
Ca2+), T is the relative tension,
K is a constant, and n is the Hill coefficient. Slope
coefficient n and pL for half-maximal activation
(pL50=-log10K/n)
were calculated for each bundle by means of nonlinear regression
analysis. To determine the rate constant of tension recovery,
quick length changes (0.3% to 3% of initial muscle length) were
applied in the relaxing and activating solutions, as previously
described.18 The rate constant of tension recovery
after quick stretches was calculated by a least-squares regression
analysis, according to a single-exponential model, between 50%
and 80% of recovery and using stretches of >1%.
Estimation of Ca2+ Loading by SR
The technique for assessing SR function using caffeine-induced
tension transient in saponin-skinned fibers was a modified version of
the one described previously14 in the same experimental
setup as for mechanical experiments. Experiments were performed at
22°C in solutions containing (except otherwise stated) (in
mmol/L) EGTA 10; BES 60 (pH 7.1), Na+ 30.6,
Mg2+ 0.8, DTT 0.3, sodium azide 2, leupeptin
0.02, ionic strength 160 (potassium methanesulphonate), MgATP 3.16, and
PCr 12, with varying amounts of calcium.
After emptying the SR by brief application of caffeine (5 mmol/L), loading was carried out in strongly buffered (10 mmol/L EGTA) loading solutions at pCa 6.25. Each fiber was randomly loaded for 10, 30, 60, 180, and 420 seconds in the presence of either MgATP+PCr (control load) or ATP alone (ATP load). To assess efficacy of glycolysis in supporting calcium uptake, SR was loaded for 420 seconds in the presence of (in mmol/L) MgADP 1+NAD+ 4+glyceraldehyde 3-P 6+Pi 2 (glycolytic load), which allows activation of the 2 ATP-generating steps of glycolysis, PGK and PK.
The caffeine-induced tension transient was used to calculate the time course of free [Ca2+] close to myofibrils during the release, taking the pCa/tension dependence as internal calibration, as previously described.14 For this purpose, the pCa/tension relationship in the presence of 5 mmol/L caffeine was obtained at the end of each experiment, and tensions were normalized with respect to the maximal calcium-activated tension. The data from each fiber were fitted to the Hill equation, and the [Ca2+] at each step of the tension-time integral was recalculated using Labview software (National Instruments Corp) to obtain [Ca2+]xtime integrals (SCa), which were taken to evaluate the SR Ca2+ loading capacity.
Statistical Analysis
The data are expressed as mean±SEM. A Student t test
was used to determine the statistical difference of means between the
sham and CHF groups. A paired t test was used to compare
tension and calcium-time integral obtained in different substrates
within each group. SCa values were
analyzed by ANOVA using a 2 (load)x2 (condition [sham or
CHF])x5 (time) factorial design with repeated measures. When a
significant F ratio was found, a Newman-Keuls test was used to detect
differences between groups. Values of P<0.05 were
considered significant.
| Results |
|---|
|
|
|---|
|
Experiments with isolated perfused hearts confirmed that CHF hearts
exhibit systolic and diastolic abnormalities that
characterize heart failure (Table 1
). LVDP was not different
between the 2 groups but decreased by 39% when normalized per grams of
left ventricle. LVEDP was significantly higher in CHF than in sham
rats. This was associated with a 28% decrease in
QO2.
Biochemical Data
Enzyme activities are presented in Table 2
. The total protein content of CHF
myocardium was slightly lower and interstitial
collagen was higher in CHF myocardium, evidencing signs of
edema and increased fibrosis with broad variations from heart to heart.
Enzyme activities were thus reported per mg protein using the Lowry
method, which minimizes the contribution of aromatic amino acid
residues abundant in collagen.28 The activity of AK, a
phosphotransfer enzyme, was unchanged in CHF. LDH activity was also
unchanged in CHF myocardium, but the proportion of the
cardiac aerobic subunit (H-LDH) was significantly decreased. PK and
PGK, the 2 steps of glycolytically produced ATP, were decreased as well
in CHF. Citrate synthase activity, a marker of mitochondrial capacities
or mitochondrial mass, was decreased by 33%.
|
CK System
CK activity and isoenzyme profile, whether expressed as IU/mg
protein or as percentage of total CK activity, were greatly affected in
CHF rats (Table 3
). Total CK activity was
reduced by 45%, with great differences among the 4 isoenzymes.
Although the relative proportion of the B isoform of CK (BB-CK)
increased in CHF myocardium (+136%), the activity was
maintained, as was the activity of the B-subunit (BB-CK+1/2MB).
Activity of MM-CK and the heterodimer of B and M CK (MB-CK) exhibited a
30% to 40% decrease. The most dramatic change was an 83% decrease in
the mi-CK isoform. This decrease exceeded the overall decrease in
mitochondrial activity, since the mi-CK to citrate synthase ratio
exhibited a 4-fold decrease. Western blot analysis of
mitochondrial CK protein (Figure 1
and Table 3
) showed that this decrease could be entirely
accounted for by a decrease in mi-CK protein content with no change in
the enzyme specific activity.
|
|
Mitochondrial Function and CK
To establish the functional consequences of the decrease in mi-CK
on mitochondrial regulation, oxygen consumption of
permeabilized preparations from control (sham) and
experimental (CHF) rats was recorded as a function of ADP
concentration (Figure 2
) in the absence
or in the presence of creatine. As ADP concentration increased,
respiration rate reached a plateau that was significantly lower in
failing than in control hearts. The addition of creatine shifted the
relationship toward lower ADP concentrations, both in sham and CHF,
although to a lesser extent in the latter. The relationship between
respiration rate and ADP concentration could be reasonably fitted by
the Michaelis-Menten equation. The averaged results are
presented in Table 4
. Maximal and
basal respiration rates showed a
30% reduction, which suggests a
decrease in oxidative capacities in CHF. As the acceptor control ratio
was high and preserved in CHF, this decrease suggested a decreased
amount of mitochondria without changes in the
oxidation-phosphorylation coupling. Indeed, reduced
respiration correlated to reduced mitochondrial content assessed by
citrate synthase activity. In the absence of creatine, the
Km for ADP was significantly higher in CHF
than in sham. After addition of creatine, the decrease in
Km for ADP (CK efficacy) was less in CHF
(2.3 times) than in sham (4 times). The stimulation of respiration by
AMP in the presence of ATP was 70% in sham and only 45% in CHF
(P=0.02), which shows an impairment of mitochondrial AK
efficacy as well.
|
|
It thus appeared that both the maximal capacities and the regulation of mitochondria were altered in CHF.
SR Function and CK
The function of the SR was studied in saponin-skinned fibers
loaded with Ca2+ for different periods of time
and emptied by the application of 5 mmol/L caffeine. The tension
transients were used to estimate calcium uptake and release properties
of the SR of sham and CHF myocardium. Because the calcium
sensitivity of tension development in the presence of caffeine was
higher in CHF (pCa50=5.824±0.012) than in sham
(5.776±0.012, P=0.017), the
[Ca2+]xtime integral
(SCa) was recalculated from tension transients by
using the calcium sensitivity of tension development for each fiber to
minimize any difference caused by myofilament
properties.14 SCa reflects the
amount of calcium released by the SR and reaching myofilaments.
SCa was plotted as a function of the loading time
in sham (Figure 3A
) and CHF
(Figure 3B
). When MgATP was the only substrate,
SCa increased slightly with time. There was no
difference between sham and CHF. When PCr was added in sham,
SCa increased sharply, reaching a 3.2 times
higher value for a 420-second load than with MgATP alone. In CHF
(Figure 3B
), for a 420-second load, SCa
was 23% lower than in sham in the presence of both substrates
(41.0±4.1 µmol/Lxseconds in sham versus 31.7±3.2
µmol/Lxseconds in CHF, P=0.01). It appeared, therefore,
that the addition of PCr enhanced calcium uptake to a much lower extent
in CHF (Figure 3C
). For a 420-second load, PCr increased
SCa 3.2 times in sham but only 2.4 times in CHF
(P=0.004) (CK efficacy). To investigate whether ATP supplied
by bound glycolytic enzymes could provide energy for calcium uptake and
whether this was altered in CHF, SR was loaded in the presence of
glycolytic substrates (6 mmol/L glyceraldehyde 3-P with
1 mmol/L MgADP, 4 mmol/L NAD+, and
2 mmol/L Pi). A 420-second load resulted in
a SCa reaching 107±6% of that in the presence
of ATP alone and was not significantly affected in CHF (103±9%) (data
not shown). This finding also shows that PGK and possibly PK are
present and active close to SR ATPase in skinned fibers. It thus
appeared that one main alteration in SR function in CHF was the
inability of bound CK to support calcium uptake.
|
Myofibrillar Function and CK in Left Ventricles of CHF
Rats
Myofibrillar function was studied in Triton X-100treated LV
fibers. Averaged results are listed in Table 5
. Fibers of similar diameters were
obtained from sham and CHF myocardium. Active tension
development was 24% lower in CHF (P=0.007) than in sham.
However, the sensitivity of tension development to calcium was
unchanged. The rate constant of tension changes after quick stretches,
reflecting the crossbridge cycling rate, was decreased 2.2 times in
CHF. This was accompanied by a sharp decrease in the proportion of the
fast cardiac
myosin heavy chain isoform. In the absence of
calcium, a progressive decrease in MgATP concentration leads to the
development of rigor tension. The half-maximal MgATP concentration for
rigor tension development was shifted toward much lower values in the
presence of PCr because of rapid rephosphorylation of
ADP by bound CK in the vicinity of myosin ATPase. PCr decreased the
ATP50 values to a similar degree in fibers from
CHF and sham, showing that myofibrillar CK efficacy was well preserved
in CHF myocardium.
|
| Discussion |
|---|
|
|
|---|
Alterations in CK System in Heart Failure
This study shows that, as in human heart, CK activity is largely
depressed in severe CHF in rats, and that this decrease mainly affects
mitochondrial CK activity and MM-CK. AK (another phosphotransfer
enzyme) and LDH activities were not affected, which shows that the CK
alterations were rather specific. Moreover, we show that the 4-fold
decrease in mi-CK activity was entirely accounted for by a decrease in
the mi-CK protein content that largely exceeded the decrease in
mitochondrial mass. Failure to observe consistent alterations
in CK activity or enzymes in animal models of heart
failure29 30 31 32 may thus be due to the severity and/or
duration of the disease. Indeed, our results agree with the results
obtained in end-stage heart failure in humans,5 with the
exception that MB-CK, which was decreased in rats, increased 7 times in
humans. The maintained MB-CK activity and the less dramatic decrease in
M- and particularly mi-CK in human heart may reflect the beneficial
effect of pharmacological treatments on the expression of the CK system
in humans. For example, long-term treatments by ß-blockers can
prevent the decrease in creatine and CK in an animal model of heart
failure.33
During hypertrophy and failure, the decrease in mi-CK and
mitochondrial content could represent the reactivation of a
fetal gene program that is characterized by increased ß-myosin heavy
chain, atrial natriuretic factor, and B-CK expression. However,
although B-CK expression could represent an adaptive mechanism
to a decrease in high-energy phosphates,4 decreased mi-CK
content and/or efficacy has been consistently observed in
animal models of cardiomyopathies of different
origin and is suggested to be a marker of the transition between
compensatory hypertrophy and failure (see References 34 and
3534 35 for review and references therein). Signals involved in cardiac
remodeling are not yet fully understood. Among them, numerous hormones
(eg, angiotensin and epinephrine) and
cytokines (eg, tumor necrosis factor-
), as well as
mechanical factors (eg, stretch), have been implicated in the
cardiac growth response. The signal transduction pathways could involve
protein kinase C and mitogen-activated protein kinase
activation, as well as the recently identified calcineurin
pathway.36 More work is needed to identify the factor(s)
responsible for energy deficiency in heart failure.
Myofibrillar Function and CK in Heart Failure
The contractile dysfunction that was observed in CHF (ie,
increased LVEDP and decreased LVDP per gram) may be caused by
intrinsic alterations in contractile proteins. The decrease in maximal
force reflects an overall decrease in the ability of the myocardial
tissue to develop force and could be due to a decrease in contractile
proteins or a disorganization of the myofilament structure. Such a
decrease was not observed in compensated pressure
overload.37 In CHF, no change in calcium responsiveness
was observed except in the presence of caffeine, as was previously
observed in compensated hypertrophy.37 38 The
decrease in the rate constant of tension changes reflects the decrease
in the relative amount of the fast myosin isoenzyme generally observed
in pressure overload in rat heart.39 However, in CHF,
despite a 30% decrease in total activity, MM-CK bound to myofibrils
was still able to induce a 54-fold decrease in the
ATP50 for relaxation of rigor tension
(Table 5
). The stability of myofibrillar CK could be due to the
fact that MM-CK is an integral part of the myofibrillar structure,
forming intermyosin bridges in the M line.9 On the
other hand, it could be argued that the more economic contractile
behavior of pressure-overloaded myocardium40
due to decreasing amount of the fast myosin isoform could be adequately
supplied by a lowered amount of MM-CK. It can be concluded that despite
altered myofibrillar function, the myofibrillar CK efficacy is
preserved in CHF.
Mitochondrial Function and CK
Few data are available concerning the oxidative capacities of the
failing heart. Skinned fiber studies of mitochondrial respiration offer
the unique opportunity to assess intrinsic oxidative capacities in
muscles with nonlimiting amounts of substrates and oxygen. In CHF rats,
we observed a 30% decrease in both basal and maximal respiration rates
paralleled by a 33% decrease in citrate synthase activity, which
suggests a decrease in the amount of mitochondria with preserved
coupling between oxidation and phosphorylation. This
was accompanied by a decrease in the relative proportion of the cardiac
form of LDH and decreased glycolytic ATP-regenerating steps. Decreased
oxidative capacities may explain the lower oxygen consumption rate
observed in isolated hearts. As the heart utilizes 80% to 90% of its
maximum oxidative capacities during exercise,41 decreased
aerobic capacities could by themselves limit the ATP synthesis and
contractile capacities of the failing heart and contribute to the
limited exercise capacity in heart failure.
Cardiac mitochondria maintained within the cellular architecture
exhibit regulatory properties that greatly differ from isolated
mitochondria.16 This is characterized by a low sensitivity
of mitochondrial respiration for extramitochondrial ADP, whereas
creatine addition decreases the apparent Km
for ADP because of functional coupling between oxidative
phosphorylation, translocase, and
mi-CK.16 Such a coupling has also been described for
mitochondrial AK.42 Regulation of mitochondrial
respiration by mitochondrial kinases provides a specialized system by
which different cytosolic metabolic pathways linked to
cytosolic kinases are connected to mitochondrial
respiration.43 44 45 These phosphotransfer systems may
provide an efficient integration between energy utilization and
production within oxidative tissues. In situ mitochondria from
CHF rats appeared 26% less sensitive to ADP, 58% less sensitive to
creatine, and 36% less sensitive to AMP (Table 4
) than
mitochondria from sham, showing a loss of regulation of oxidative
phosphorylation by phosphate acceptors. This suggests a
generalized loss of integration between cytosolic signals and
mitochondria in CHF, which could be responsible for altered energy
fluxes and incapacity of the failing myocardium to adapt
energy production to energy utilization and to mobilize
contractile reserve.6
SR Function and CK in Heart Failure
A crucial alteration in SR function was that the increase in
calcium uptake brought about by addition of PCr in the presence of ATP
was lower in CHF than in sham (Figure 3
). This is the first
demonstration of a possible alteration in SR function by decreased
efficacy of bound CK. The decreased efficacy may be attributed to
decreased amount of bound MM-CK in SR or disorganization of SR
architecture, leading to looser coupling between
Ca2+-ATPase and CK.
It is generally assumed that a defect in the capacity of the SR to accumulate calcium participates in the pathophysiology of heart failure. Changes in expression of the different proteins involved in calcium uptake and calcium release by the SR has received much attention, and there is evidence that Ca2+ ATPase is down-regulated in the CHF model used in this study.17 However, efficiency of the calcium pump also depends on adequate energy supply and effective withdrawal of the end products of ATP hydrolysis. Indeed, ATP and ADP exert a kinetic (through affinity and inhibition constants) as well as thermodynamic (through free energy of ATP hydrolysis) control on calcium uptake. A functional coupling between SR Ca2+ ATPase and bound CK allows the maintenance of a high ATP/ADP ratio in the close vicinity of the catalytic site, an adequate energy supply, and relief of product inhibition on the ATPase,11 12 13 thus markedly enhancing the calcium uptake capacity of the SR.14 Implication of MM-CK in kinetics and amplitude of the calcium transient was recently underscored in skeletal muscle of mice deficient in MM-CK46 and in CK-inhibited rat hearts.47
CK System and Heart Failure
The pathogenesis of heart failure is as yet not clearly
defined, and the two main hypotheses so far put forward are (1)
inadequate calcium uptake and release and (2) mismatch between energy
production and utilization. However, these 2 cellular events
are closely interrelated. Calcium withdrawal depends on efficient
energy-driven calcium pumps and, secondarily, sodium pumps, whereas
calcium concentration determines energy expenditure through cellular
ATPases. Each of these steps depends on the subcellular architecture
and protein organization. Increasing evidence also supports the
proposal that localized control of energy fluxes influences calcium
homeostasis and contractility. Disturbances in
one of these finely controlled cellular processes will make the myocyte
enter a vicious cycle of energy mismatch and calcium dysregulation,
especially in periods of increased workload.
An alteration in energy metabolism in CHF was demonstrated by (1) decreased oxidative capacity, (2) altered glycolytic pathway, (3) altered expression of the CK system, (4) altered regulation of mitochondrial respiration by phosphate acceptors, and (5) decreased control of localized energy fluxes by bound CKs in mitochondria and SR. Moreover, whole-organ enzymology of the CK system, studied by nuclear magnetic resonance spectroscopy, showed that substrates of the CK reaction were altered in heart failure and that the capacity for ATP resynthesis was 83% lower in failing than in control myocardium.5 48 In normal heart, the fine integration between energy utilization and energy production is produced by functional coupling in which a locally increased ADP is quickly rephosphorylated and the amplified signal is transmitted through the cytosolic energy transfer systems (CK and AK) to mitochondria, where it can stimulate respiration.16 45 In CHF, this fine regulation is impaired, leading to mismatch between synthesis and utilization of energy, and the decreased PCr/ATP ratio7 most probably reflects the chronic imbalance between ATP supply and demand. Decreased efficacy of SR-bound CK to control adenine nucleotides in the vicinity of SR Ca2+ ATPase could contribute to the slowing of calcium uptake and twitch relaxation and to increased diastolic calcium concentration in CHF.49 50 51
| Acknowledgments |
|---|
Received February 1, 1999; accepted April 21, 1999.
| References |
|---|
|
|
|---|
2.
Phillips RM, Narayan P, Gomez AM, Dilly K, Jones LR,
Lederer WJ, Altschuld RA. Sarcoplasmic reticulum in heart failure:
central player or bystander? Cardiovasc Res. 1998;37:346351.
3.
Hasenfuss G. Alterations of calcium-regulatory
proteins in heart failure. Cardiovasc Res. 1998;37:279289.
4. Ingwall JS. Is cardiac failure a consequence of decreased energy reserve? Circulation. 1993;87(suppl VII):VII58VII62.
5.
Nascimben L, Ingwall JS, Pauletto P, Friedrich J,
Gwathmey JK, Saks V, Pessina AC, Allen PD. Creatine kinase system in
failing and nonfailing human myocardium.
Circulation. 1996;94:18941901.
6.
Liao RL, Nascimben L, Friedrich J, Gwathmey JK,
Ingwall JS. Decreased energy reserve in an animal model of dilated
cardiomyopathy: relationship to contractile
performance. Circ Res. 1996;78:893902.
7.
Neubauer S, Horn M, Cramer M, Harre K, Newell JB,
Peters W, Pabst T, Ertl G, Hahn D, Ingwall JS, Kochsiek K. Myocardial
phosphocreatine-to-ATP ratio is a predictor of mortality in patients
with dilated cardiomyopathy.
Circulation. 1997;96:21902196.
8. Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM. Intracellular compartmentation, structure, and function of creatine kinase isoenzymes in tissues with high, and fluctuating energy demands: the phosphocreatine circuit for cellular energy homeostasis. Biochem J. 1992;281:2140.
9. Wallimann T, Eppenberger HM. Localization and function of M-line-bound creatine kinase M-band model and creatine phosphate shuttle. Cell Muscle Motil. 1985;6:239285.[Medline] [Order article via Infotrieve]
10. Ventura-Clapier R, Veksler V, Hoerter JA. Myofibrillar creatine kinase and cardiac contraction. Mol Cell Biochem. 1994;133:125144.
11. Levitskii DO, Levchenko TS, Saks VA, Sharov VG, Smirnov VN. Functional coupling between Ca2+-ATPase and creatine phosphokinase in sarcoplasmic reticulum of myocardium. Biochimyia. 1977;42:17661773.
12.
Rossi AM, Eppenberger HM, Volpe P, Cotrufo R, Wallimann
T. Muscle-type MM creatine kinase is specifically bound to sarcoplasmic
reticulum and can support Ca2+ uptake and
regulate local ATP/ADP ratios. J Biol Chem. 1990;265:52585266.
13. Korge P, Byrd SK, Campbell KB. Functional coupling between sarcoplasmic-reticulum-bound creatine kinase and Ca2+ ATPase. Eur J Biochem. 1993;213:973980.[Medline] [Order article via Infotrieve]
14. Minajeva A, Ventura-Clapier R, Veksler V. Ca2+ uptake by cardiac sarcoplasmic reticulum ATPase in situ strongly depends on bound creatine kinase. Pflügers Arch. 1996;432:904912.
15. Wyss M, Smeitink J, Wevers RA, Wallimann T. Mitochondrial creatine kinase: a key enzyme of aerobic energy metabolism. Biochim Biophys Acta. 1992;1102:119166.[Medline] [Order article via Infotrieve]
16. Saks VA, Khuchua ZA, Vasilyeva EV, Belikova OY, Kuznetsov AV. Metabolic compartmentation and substrate channeling in muscle cells: role of coupled creatine kinases in in vivo regulation of cellular respiration: a synthesis. Mol Cell Biochem. 1994;133:155192.
17. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res. 1993;73:184192.[Abstract]
18.
Ventura-Clapier R, Kuznetsov AV, d'Albis A, van
Deursen J, Wieringa B, Veksler VI. Muscle creatine kinase-deficient
mice, 1: alterations in myofibrillar function. J Biol
Chem. 1995;270:1991419920.
19.
Veksler VI, Kuznetsov AV, Anflous K, Mateo P, van
Deursen J, Wieringa B, Ventura-Clapier R. Muscle creatine
kinase-deficient mice, 2: cardiac and skeletal muscles exhibit
tissue-specific adaptation of the mitochondrial function. J
Biol Chem. 1995;270:1992119929.
20. Srere PA. Citrate synthase. Methods Enzymol. 1969;13:311.
21. d'Albis A, Pantaloni C, Béchet JJ. An electrophoretic study of native myosin isoenzymes and their subunit content. Eur J Biochem. 1979;99:261272.[Medline] [Order article via Infotrieve]
22. d'Albis A, Couteaux R, Janmot C, Roulet A. Specific programs of myosin expression in the postnatal development of rat muscles. Eur J Biochem. 1989;183:583590.[Medline] [Order article via Infotrieve]
23. Steeghs K, Heerschap A, deHaan A, Ruitenbeek W, Oerlemans F, vanDeursen J, Perryman B, Pette D, Bruckwilder M, Koudijs J, Jap P, Wieringa B. Use of gene targeting for compromising energy homeostasis in neuro-muscular tissues: the role of sarcomeric mitochondrial creatine kinase. J Neurosci Methods. 1997;71:2941.[Medline] [Order article via Infotrieve]
24. Veksler VI, Kuznetsov AV, Sharov VG, Kapelko VI, Saks VA. Mitochondrial respiratory parameters in cardiac tissue: a novel method of assessment by using saponin-skinned fibers. Biochim Biophys Acta. 1987;892:191196.[Medline] [Order article via Infotrieve]
25. Saks VA, Khuchua ZA, Kuznetsov AV, Veksler VI, Sharov VG. Heart mitochondria in physiological salt solution: not ionic strength but salt composition is important for association of creatine kinase with the inner membrane surface. Biochem Biophys Res Commun. 1986;139:12621271.[Medline] [Order article via Infotrieve]
26. Fabiato A. Computer programs for calculating total from specified free or free from specified total ionic concentrations in aqueous solutions containing multiple metals and ligands. Methods Enzymol. 1988;157:378417.[Medline] [Order article via Infotrieve]
27.
Ventura-Clapier R, Mekhfi H, Vassort G. Role of
creatine kinase in force development in chemically skinned rat cardiac
muscle. J Gen Physiol. 1987;89:815837.
28. Tian R, Nascimben L, Kaddurah-Daouk R, Ingwall JS. Depletion of energy reserve via the creatine kinase reaction during the evolution of heart failure in cardiomyopathic hamsters. J Mol Cell Cardiol. 1996;28:755765.[Medline] [Order article via Infotrieve]
29. Schultz D, Su XF, Bishop SP, Billadello J, Dell'Italia LJ. Selective induction of the creatine kinase-B gene in chronic volume overload hypertrophy is not affected by ACE-inhibitor therapy. J Mol Cell Cardiol. 1997;29:26652673.[Medline] [Order article via Infotrieve]
30. Hoang CD, Zhang JY, Payne RM, Apple FS. Postinfarction left ventricular remodeling induces changes in creatine kinase mRNA and protein subunit levels in porcine myocardium. Am J Pathol. 1997;151:257264.[Abstract]
31. Neubauer S, Frank M, Hu K, Remkes H, Laser A, Horn M, Ertl G, Lohse MJ. Changes of creatine kinase gene expression in rat heart post-myocardial infarction. J Mol Cell Cardiol. 1998;30:803810.[Medline] [Order article via Infotrieve]
32.
Williams RE, Kass DA, Kawagoe Y, Pak P, Tunin RS, Shah
R, Hwang A, Feldman AM. Endomyocardial gene
expression during development of pacing tachycardia-induced
heart failure in the dog. Circ Res. 1994;75:615623.
33. Laser A, Neubauer S, Tian R, Hu K, Gaudron P, Ingwall JS, Ertl G. Long-term beta-blocker treatment prevents chronic creatine kinase and lactate dehydrogenase system changes in rat hearts after myocardial infarction. J Am Coll Cardiol. 1996;27:487493.[Abstract]
34. Veksler V, Ventura-Clapier R. In situ study of myofibrils, mitochondria and bound creatine kinases in experimental cardiomyopathies. Mol Cell Biochem. 1994;133:287298.
35. Khuchua ZA, Vasilieva EV, Clark JF, Korchazhkina OV, Branishe T, Kapelko VI, Kuznetsov AV, Ventura-Clapier R, Steinschneider AY, Lakomkin VL, Ruuge EK, Saks VA. The creatine kinase system and cardiomyopathy. Am J Cardiovasc Pathol. 1992;4:223234.[Medline] [Order article via Infotrieve]
36. Molkentin JD, Lu J-R, Antos CL, Markham B, Richardson J, Robbins J, Grant SR, Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215228.[Medline] [Order article via Infotrieve]
37.
Ventura-Clapier R, Mekhfi H, Oliviero P, Swynghedauw B.
Pressure overload changes cardiac skinned fiber mechanics in rat, not
in guinea pig. Am J Physiol. 1988;254:H517H524.
38. Baudet S, Ventura-Clapier R. Differential effects of caffeine on skinned fibers from control and hypertrophied ferret hearts. Am J Physiol. 1990;259:H1908H1808.
39.
Swynghedauw B. Developmental and functional adaptation
of contractile proteins in cardiac and skeletal muscles. Physiol
Rev. 1986;66:710771.
40. Hasenfuss G, Mulieri LA, Holubarsch C, Blanchard EM, Just H, Alpert NR. Myocardial adaptation to stress from the viewpoint of adaptation and development. Basic Res Cardiol. 1993;88:91102.
41. Mootha VK, Arai AE, Balaban RS. Maximum oxidative phosphorylation capacity of the mammalian heart. Am J Physiol. 1997;41:H769H775.
42. Laterveer FD, Nicolay K, Gellerich FN. ADP delivery from adenylate kinase in the mitochondrial intermembrane space to oxidative phosphorylation increases in the presence of macromolecules. FEBS Lett. 1996;386:255259.[Medline] [Order article via Infotrieve]
43. Brdiczka D, Wallimann T. The importance of the outer mitochondrial compartment in regulation of energy metabolism. Mol Cell Biochem. 1994;133:6983.
44. Saks V, Dos Santos P, Gellerich FN, Diolez P. Quantitative studies of enzyme-substrate compartmentation, functional coupling and metabolic channeling in muscle cells. Mol Cell Biochem. 1998;184:291307.[Medline] [Order article via Infotrieve]
45. Dzeja PP, Zeleznikar RJ, Goldberg ND. Adenylate kinase: kinetic behaviour in intact cells indicates it is integral to multiple cellular processes. Mol Cell Biochem. 1998;184:169182.[Medline] [Order article via Infotrieve]
46. Steeghs K, Benders A, Oerlemans F, deHaan A, Heerschap A, Ruitenbeek W, Jost C, van Deursen J, Perryman B, Pette D, Bruckwilder M, Koudijs J, Jap P, Veerkamp J, Wieringa B. Altered Ca2+ responses in muscles with combined mitochondrial and cytosolic creatine kinase deficiencies. Cell. 1997;89:93103.[Medline] [Order article via Infotrieve]
47.
Tian R, Halow JM, Meyer M, Dillmann WH, Figueredo VM,
Ingwall JS, Camacho SA. Thermodynamic limitation for
Ca2+ handling contributes to decreased
contractile reserve in rat hearts. Am J Physiol. 1998;275:H2064H2071.
48.
Zhang J, Wilke N, Wang Y, Zhang Y, Wang CS,
Eijgelshoven MHJ, Cho YK, Murakami Y, Ugurbil K, Bache RJ, From AH.
Functional and bioenergetic consequences of postinfarction left
ventricular remodeling in a new porcine model: MRI and
31P MRS study. Circulation. 1996;94:10891100.
49. O'Brien PJ, Gwathmey JK. Myocardial Ca2+- and ATP-cycling imbalances in end-stage dilated and ischemic cardiomyopathies. Cardiovasc Res. 1995;30:394404.[Medline] [Order article via Infotrieve]
50.
Gwathmey JK, Copelas L, MacKinnon R, Schoen FJ, Feldman
MD, Grossman W, Morgan JP. Abnormal intracellular calcium handling in
myocardium from patients with end-stage heart failure.
Circ Res. 1987;61:7076.
51.
Hasenfuss G, Mulieri LA, Leavitt BJ, Allen PD, Haeberle
JR, Alpert NR. Alteration of contractile function and
excitation-contraction coupling in dilated
cardiomyopathy. Circ Res. 1992;70:12251232.
This article has been cited by other articles:
![]() |
J. S. Ingwall Energy metabolism in heart failure and remodelling Cardiovasc Res, February 15, 2009; 81(3): 412 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Joubert, J. R. Wilding, D. Fortin, V. Domergue-Dupont, M. Novotova, R. Ventura-Clapier, and V. Veksler Local energetic regulation of sarcoplasmic and myosin ATPase is differently impaired in rats with heart failure J. Physiol., November 1, 2008; 586(21): 5181 - 5192. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Ciobotaru, M. Heimburger, L. Louedec, C. Heymes, R. Ventura-Clapier, P. Bedossa, B. Escoubet, J.-B. Michel, J.-J. Mercadier, and D. Logeart Effect of Long-Term Heart Rate Reduction by If Current Inhibition on Pressure Overload-Induced Heart Failure in Rats J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 43 - 49. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. J. Kemi, M. A. Hoydal, P. M. Haram, A. Garnier, D. Fortin, R. Ventura-Clapier, and O. Ellingsen Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan Cardiovasc Res, October 1, 2007; 76(1): 91 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Brixius, R. Lu, B. Boelck, S. Grafweg, F. Hoyer, C. Pott, U. Mehlhorn, W. Bloch, and R. H. G. Schwinger Chronic Treatment with Carvedilol Improves Ca2+-Dependent ATP Consumption in Triton X-Skinned Fiber Preparations of Human Myocardium J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 222 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Neubauer The Failing Heart -- An Engine Out of Fuel N. Engl. J. Med., March 15, 2007; 356(11): 1140 - 1151. [Full Text] [PDF] |
||||
![]() |
Y. Athea, B. Viollet, P. Mateo, D. Rousseau, M. Novotova, A. Garnier, S. Vaulont, J. R. Wilding, A. Grynberg, V. Veksler, et al. AMP-Activated Protein Kinase {alpha}2 Deficiency Affects Cardiac Cardiolipin Homeostasis and Mitochondrial Function Diabetes, March 1, 2007; 56(3): 786 - 794. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Callahan and G. S. Supinski Diaphragm and cardiac mitochondrial creatine kinases are impaired in sepsis J Appl Physiol, January 1, 2007; 102(1): 44 - 53. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ventura-Clapier, B. Mettauer, and X. Bigard Beneficial effects of endurance training on cardiac and skeletal muscle energy metabolism in heart failure Cardiovasc Res, January 1, 2007; 73(1): 10 - 18. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Wilding, F. Joubert, C. de Araujo, D. Fortin, M. Novotova, V. Veksler, and R. Ventura-Clapier Altered energy transfer from mitochondria to sarcoplasmic reticulum after cytoarchitectural perturbations in mice hearts J. Physiol., August 15, 2006; 575(1): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zoll, L. Monassier, A. Garnier, B. N'Guessan, B. Mettauer, V. Veksler, F. Piquard, R. Ventura-Clapier, and B. Geny ACE inhibition prevents myocardial infarction-induced skeletal muscle mitochondrial dysfunction J Appl Physiol, August 1, 2006; 101(2): 385 - 391. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Eimre, R. Puhke, K. Alev, E. Seppet, A. Sikkut, N. Peet, L. Kadaja, A. Lenzner, T. Haviko, T. Seene, et al. Altered mitochondrial apparent affinity for ADP and impaired function of mitochondrial creatine kinase in gluteus medius of patients with hip osteoarthritis Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2006; 290(5): R1271 - R1275. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Parlakian, C. Charvet, B. Escoubet, M. Mericskay, J. D. Molkentin, G. Gary-Bobo, L. J. De Windt, M.-A. Ludosky, D. Paulin, D. Daegelen, et al. Temporally Controlled Onset of Dilated Cardiomyopathy Through Disruption of the SRF Gene in Adult Heart Circulation, November 8, 2005; 112(19): 2930 - 2939. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Stanley, F. A. Recchia, and G. D. Lopaschuk Myocardial Substrate Metabolism in the Normal and Failing Heart Physiol Rev, July 1, 2005; 85(3): 1093 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Helies-Toussaint, C. Moinard, C. Rasmusen, I. Tabbi-Anneni, L. Cynober, and A. Grynberg Aortic banding in rat as a model to investigate malnutrition associated with heart failure Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1325 - R1331. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Burelle, R. B. Wambolt, M. Grist, H. L. Parsons, J. C. F. Chow, C. Antler, A. Bonen, A. Keller, G. A. Dunaway, K. M. Popov, et al. Regular exercise is associated with a protective metabolic phenotype in the rat heart Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1055 - H1063. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Momken, P. Lechene, R. Ventura-Clapier, and V. Veksler Voluntary physical activity alterations in endothelial nitric oxide synthase knockout mice Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H914 - H920. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Ingwall and R. G. Weiss Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function Circ. Res., July 23, 2004; 95(2): 135 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ventura-Clapier, A. Garnier, and V. Veksler Energy metabolism in heart failure J. Physiol., February 15, 2004; 555(1): 1 - 13. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Garnier, D Fortin, C Delomenie, I Momken, V Veksler, and R Ventura-Clapier Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles J. Physiol., September 1, 2003; 551(2): 491 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Gong, J. Liu, P. Liang, T. Guo, Q. Hu, K. Ochiai, M. Hou, Y. Ye, X. Wu, A. Mansoor, et al. Oxidative capacity in failing hearts Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H541 - H548. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zoll, B. N'Guessan, F. Ribera, E. Lampert, D. Fortin, V. Veksler, X. Bigard, B. Geny, J. Lonsdorfer, R. Ventura-Clapier, et al. Preserved response of mitochondrial function to short-term endurance training in skeletal muscle of heart transplant recipients J. Am. Coll. Cardiol., July 2, 2003; 42(1): 126 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Ribera, B. N'Guessan, J. Zoll, D. Fortin, B. Serrurier, B. Mettauer, X. Bigard, R. Ventura-Clapier, and E. Lampert Mitochondrial Electron Transport Chain Function Is Enhanced in Inspiratory Muscles of Patients with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2003; 167(6): 873 - 879. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Pye, F. Ardeshirpour, A. McCain, D. A. Bellinger, E. Merricks, J. Adams, P. J. Elliott, C. Pien, T. H. Fischer, A. S. Baldwin Jr., et al. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H919 - H926. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Queiroz, Y. Shao, D. A. Berkich, K. F. Lanoue, and F. Ismail-Beigi Thyroid hormone regulation of cardiac bioenergetics: role of intracellular creatine Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2527 - H2533. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. De Sousa, P. Lechene, D. Fortin, B. N'Guessan, S. Belmadani, X. Bigard, V. Veksler, and R. Ventura-Clapier Cardiac and skeletal muscle energy metabolism in heart failure: beneficial effects of voluntary activity Cardiovasc Res, November 1, 2002; 56(2): 260 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Ventura-Clapier, E. De Sousa, and V. Veksler Metabolic Myopathy in Heart Failure Physiology, October 1, 2002; 17(5): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Zoll, H Sanchez, B N'Guessan, F Ribera, E Lampert, X Bigard, B Serrurier, D Fortin, B Geny, V Veksler, et al. Physical activity changes the regulation of mitochondrial respiration in human skeletal muscle J. Physiol., August 15, 2002; 543(1): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Burelle and P. W. Hochachka Endurance training induces muscle-specific changes in mitochondrial function in skinned muscle fibers J Appl Physiol, June 1, 2002; 92(6): 2429 - 2438. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Joubert, J.-L. Mazet, P. Mateo, and J. A. Hoerter 31P NMR Detection of Subcellular Creatine Kinase Fluxes in the Perfused Rat Heart. CONTRACTILITY MODIFIES ENERGY TRANSFER PATHWAYS J. Biol. Chem., May 17, 2002; 277(21): 18469 - 18476. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang and D. S Steele Effects of phosphocreatine on SR Ca2+ regulation in isolated saponin-permeabilized rat cardiac myocytes J. Physiol., March 15, 2002; 539(3): 767 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Mettauer, J. Zoll, H. Sanchez, E. Lampert, F. Ribera, V. Veksler, X. Bigard, P. Mateo, E. Epailly, J. Lonsdorfer, et al. Oxidative capacity of skeletal muscle in heart failure patients versus sedentary or active control subjects J. Am. Coll. Cardiol., October 1, 2001; 38(4): 947 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Liu, C. Wang, Y. Murakami, G. Gong, Y. Ishibashi, C. Prody, K. Ochiai, R. J. Bache, C. Godinot, and J. Zhang Mitochondrial ATPase and high-energy phosphates in failing hearts Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1319 - H1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mihm, F. Yu, C. A. Carnes, P. J. Reiser, P. M. McCarthy, D. R. Van Wagoner, and J. A. Bauer Impaired Myofibrillar Energetics and Oxidative Injury During Human Atrial Fibrillation Circulation, July 10, 2001; 104(2): 174 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ye, C. Wang, J. Zhang, Y. K. Cho, G. Gong, Y. Murakami, and R. J. Bache Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H376 - H386. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Mihm, C. M. Coyle, B. L. Schanbacher, D. M. Weinstein, and J. A. Bauer Peroxynitrite induced nitration and inactivation of myofibrillar creatine kinase in experimental heart failure Cardiovasc Res, March 1, 2001; 49(4): 798 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marin-Garcia, M. J Goldenthal, and G. W Moe Mitochondrial pathology in cardiac failure Cardiovasc Res, January 1, 2001; 49(1): 17 - 26. [Full Text] [PDF] |
||||
![]() |
G. S. Nelson, R. D. Berger, B. J. Fetics, M. Talbot, J. C. Spinelli, J. M. Hare, and D. A. Kass Left Ventricular or Biventricular Pacing Improves Cardiac Function at Diminished Energy Cost in Patients With Dilated Cardiomyopathy and Left Bundle-Branch Block Circulation, December 19, 2000; 102(25): 3053 - 3059. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. De Sousa, V. Veksler, X. Bigard, P. Mateo, and R. Ventura-Clapier Heart Failure Affects Mitochondrial but Not Myofibrillar Intrinsic Properties of Skeletal Muscle Circulation, October 10, 2000; 102(15): 1847 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pucar, P. P. Dzeja, P. Bast, N. Juranic, S. Macura, and A. Terzic Cellular Energetics in the Preconditioned State. PROTECTIVE ROLE FOR PHOSPHOTRANSFER REACTIONS CAPTURED BY 18O-ASSISTED 31P NMR J. Biol. Chem., November 21, 2001; 276(48): 44812 - 44819. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Boudina, M. N. Laclau, L. Tariosse, D. Daret, G. Gouverneur, S. Bonoron-Adele, V. A. Saks, and P. Dos Santos Alteration of mitochondrial function in a model of chronic ischemia in vivo in rat heart Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H821 - H831. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yang and D. S. Steele Effects of phosphocreatine on SR Ca2+ regulation in isolated saponin-permeabilized rat cardiac myocytes J. Physiol., February 1, 2002; (2002) 200101298. [Abstract] [PDF] |
||||
![]() |
A. Kaasik, V. Veksler, E. Boehm, M. Novotova, A. Minajeva, and R. Ventura-Clapier Energetic Crosstalk Between Organelles: Architectural Integration of Energy Production and Utilization Circ. Res., July 20, 2001; 89(2): 153 - 159. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |